Athira Pharma files $300M mixed securities shelf
PremiumThe FlyAthira Pharma files $300M mixed securities shelf
20d ago
Athira Pharma downgraded to Neutral from Outperform at Mizuho
Premium
The Fly
Athira Pharma downgraded to Neutral from Outperform at Mizuho
2M ago
Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
Premium
The Fly
Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
2M ago
Closing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings
PremiumThe FlyClosing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings
2M ago
Athira Pharma Discusses Clinical Trial and Financial Position
Premium
Company Announcements
Athira Pharma Discusses Clinical Trial and Financial Position
2M ago
Athira Pharma trading resumes
Premium
The Fly
Athira Pharma trading resumes
2M ago
Athira Pharma reports Q2 EPS (70c), consensus (74c)
PremiumThe FlyAthira Pharma reports Q2 EPS (70c), consensus (74c)
3M ago
Athira Pharma presents preclinical data on fosgonimeton at AAIC
Premium
The Fly
Athira Pharma presents preclinical data on fosgonimeton at AAIC
3M ago
Athira Pharma announces last patient completed dosing in LIFT-AD trial
Premium
The Fly
Athira Pharma announces last patient completed dosing in LIFT-AD trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100